The present invention provides a recombinantly expressed human monoclonal antibody that specifically binds to granulocyte macrophage colony stimulating factor (GM-CSF) wherein said antibody comprises a heavy chain comprising a CDR1 of SEQ ID NO: 46, a CDR2 of SEQ ID NO: 47, and a CDR3 of SEQ ID NO: 48 and a light chain comprising a CDR1 of SEQ ID NO: 49, a CDR2 of SEQ ID NO: 50, and a CDR3 of SEQ ID NO: 51.